AKERO THERAPEUTICS, INC.

Profile

Company Names

AKERO THERAPEUTICS, INC.

Addresses

70 HARBOR WAY, 3RD FLOOR, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

202-525-8399

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$45,499,989.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-12-10 
$45,499,989.00 
$45,499,989.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEVIN 
 
BITTERMAN 
DIRECTOR
PARASOL THERAPEUTICS INC   |  TARIS BIOMEDICAL INC   |  BIOLEX THERAPEUTICS, INC.   |  FOLLICA, INC   |  VISTERRA, INC.   |  KALA PHARMACEUTICALS, INC.   |  GENOCEA BIOSCIENCES, INC.   |  NEURONETICS, INC.   |  DIRECT VET MARKETING, INC.   |  EDITAS MEDICINE, INC.   |  MORPHIC HOLDING, LLC   |  ATLAS VENTURE FUND XI, L.P.   |  NAVITOR PHARMACEUTICALS, INC.   |  AKERO THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  KINASET THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  JUDO BIO INC.   |  CHROMA MEDICINE, INC.   |  REMIX THERAPEUTICS, INC.   |  GRO BIOSCIENCES INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  RENASANT BIO, INC.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
ANDREW 
 
CHENG 
EXECUTIVE OFFICER, DIRECTOR
PINNACLE MINES LTD   |  AKERO THERAPEUTICS, INC.   |  VERA THERAPEUTICS, INC.   |  ARBUTUS BIOPHARMA CORP
MARK 
 
IWICKI 
DIRECTOR
BLEND THERAPEUTICS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  KALA PHARMACEUTICALS, INC.   |  PULMATRIX, INC.   |  AKERO THERAPEUTICS, INC.   |  KALA BIO, INC.
AARON 
 
KANTOFF 
DIRECTOR
CURE FORWARD CORP.   |  SYNTIMMUNE, INC.   |  CORVIDIA THERAPEUTICS, INC.   |  AKERO THERAPEUTICS, INC.   |  RAYZEBIO, INC.   |  CEPTUR THERAPEUTICS, INC.   |  PETRICHOR SCION THERAPEUTICS LLC   |  AVALO THERAPEUTICS, INC.
AARON 
 
ROYSTON 
DIRECTOR
IMPEL NEUROPHARMA INC   |  MENLO THERAPEUTICS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  AKERO THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  SWIFT HEALTH SYSTEMS INC.   |  RAYZEBIO, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  VENTYX BIOSCIENCES, INC.   |  NEUROGASTRX, INC.   |  MAREA THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.   |  ARPEGGIO BIOSCIENCES, INC.   |  CALDERA THERAPEUTICS, INC.
GRAHAM 
 
WALMSLEY 
DIRECTOR
AKERO THERAPEUTICS, INC.   |  LOGOS GLOBAL US FUND LP   |  LOGOS OPPORTUNITIES FUND I LP   |  OLEMA PHARMACEUTICALS, INC.   |  LOGOS OPPORTUNITIES FUND III LP   |  LOGOS OPPORTUNITIES FUND IV LP   |  LOGOS OPPORTUNITIES FUND V (OFFSHORE) LP
JONATHAN 
 
YOUNG 
EXECUTIVE OFFICER
AKERO THERAPEUTICS, INC.   |  RISK PARITY COMMODITY FUND, L.P.   |  MELFORD CARE LP   |  MELFORD III GP LTD   |  SUNRIDGE AGRIBUSINESS OPPORTUNITIES III LP   |  SUNRIDGE AGRIBUSINESS OPPORTUNITIES III CO-INVEST 1 LP   |  GALAXY PLUS HEDGE FUND LLC - CHINA MODIFIED KWEB FUND (112)   |  GALAXY PLUS HEDGE FUND LLC - ENDURA METALEX AFRICAN OPPTY FUND (111)   |  PX3 PARTNERS TRAJAN LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-12-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#